122 related articles for article (PubMed ID: 7937691)
1. Effects of cholecystokinin receptor antagonist loxiglumide on rat exocrine pancreas.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1994 Jul; 9(4):425-33. PubMed ID: 7937691
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats.
Imoto I; Yamamoto M; Jia DM; Otsuki M
Int J Pancreatol; 1997 Dec; 22(3):177-85. PubMed ID: 9444548
[TBL] [Abstract][Full Text] [Related]
3. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
Nakano S; Kihara Y; Otsuki M
Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141
[TBL] [Abstract][Full Text] [Related]
4. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
[TBL] [Abstract][Full Text] [Related]
5. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats.
Otsuki M; Nakano S; Tachibana I
Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939
[TBL] [Abstract][Full Text] [Related]
6. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
7. Effects of loxiglumide on pancreatic exocrine secretion stimulated by meal in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Edano K; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):55-7. PubMed ID: 9522033
[TBL] [Abstract][Full Text] [Related]
8. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
9. Duration and potency of anticholecystokinin action of subcutaneous and oral loxiglumide on cerulein-stimulated pancreatic exocrine secretion.
Watanabe N; Otsuki M
Int J Pancreatol; 1993 Apr; 13(2):129-37. PubMed ID: 8501354
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholecystokinin1 receptor antagonist loxiglumide (CR1505) on basal pancreatic exocrine secretion in conscious rats.
Ishizaki K; Kinbara S; Kawamura M; Kimura K; Shiratori K; Takeuchi T
Pancreas; 2003 Jan; 26(1):87-91. PubMed ID: 12499923
[TBL] [Abstract][Full Text] [Related]
11. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
12. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
13. A cholecystokinin receptor antagonist, loxiglumide, stimulates biliary secretion in conscious rats.
Watanabe N; Otsuki M
Eur J Pharmacol; 1994 Nov; 264(3):331-6. PubMed ID: 7698173
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion.
Tanikawa M; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Kodaira T; Hamaoka T
Arzneimittelforschung; 1993 Jan; 43(1):35-9. PubMed ID: 8447844
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
Varga G; Papp M; Scarpignato C
Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
[TBL] [Abstract][Full Text] [Related]
18. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
[TBL] [Abstract][Full Text] [Related]
20. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat.
Beckh K; Göke R; Ruff W; Koop I; Arnold R; Adler G
Digestion; 1991; 48(2):98-103. PubMed ID: 1868975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
